SearchDictionaryMobileLogin

Morito Monden Selected Research

Neoplasm Metastasis (Metastasis)

04/2008Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis.
02/2008Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer.
01/2008Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma.
06/2007Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
11/2006A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
01/2006Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
01/2006Complete response of highly advanced colon cancer with multiple lymph node metastases to irinotecan combined with UFT: report of a case.
10/2005[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha]
10/2005[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]
10/2004[Case report--Complete response of liver metastasis of rectal cancer after combination chemotherapy of CPT-11 + UFT-E]
10/2004[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy]
10/2004[Successful treatment for advanced cholangiocellular carcinoma with intrahepatic metastasis and/or portal vein tumor thrombi by intraarterial chemotherapy combined with 5-fluorouracil, adriamycin and cisplatin (FAP)--two cases report]
02/2004Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
10/2003[A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy]
02/2003[A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine]
01/2003Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil.
11/2002[A case of postoperative multiple hepatic metastasis from gastric cancer successfully treated by percutaneous microwave coagulation therapy and hepatic arterial infusion chemotherapy]
06/2002Extraction and analysis of carcinoembryonic antigen in lymph nodes: a new approach to the diagnosis of lymph node metastasis of colorectal cancer.

Articles by Research Topic

Disease

49Hepatocellular Carcinoma (Hepatoma)
04/2008 - 01/2002
29Neoplasms (Cancer)
03/2008 - 01/2002
18Neoplasm Metastasis (Metastasis)
04/2008 - 06/2002
18Stomach Neoplasms (Stomach Cancer)
11/2007 - 05/2002
12Carcinoma (Carcinomatosis)
03/2008 - 04/2002
9Thrombosis (Thrombus)
12/2007 - 02/2005
8Esophageal Neoplasms (Esophageal Cancer)
05/2008 - 07/2002
8Colorectal Neoplasms (Colorectal Cancer)
02/2008 - 06/2002
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2008 - 08/2003
4Colonic Neoplasms (Colon Cancer)
02/2006 - 05/2005
4Breast Neoplasms (Breast Cancer)
08/2004 - 07/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2008 - 01/2007
3Adenocarcinoma
02/2004 - 09/2003
2Anoxia (Hypoxia)
05/2006 - 04/2006
2Rectal Neoplasms (Rectal Cancer)
01/2006 - 10/2004
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2008
1Aggressive Fibromatosis (Desmoid)
03/2008
1Cholestasis
01/2008
1Thrombocytopenia (Thrombopenia)
11/2007
1Hyperbilirubinemia
11/2007
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2006
1Hepatitis C
01/2006
1Gallbladder Neoplasms (Gallbladder Cancer)
10/2004
1Interstitial Lung Diseases (Interstitial Lung Disease)
08/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2004
1Thyroid Neoplasms (Thyroid Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

24Fluorouracil (Carac)FDA LinkGeneric
01/2008 - 01/2002
20Interferon-alpha (Interferon Alfa)FDA Link
04/2008 - 01/2002
9Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 10/2003
7CDC48 proteinIBA
08/2004 - 02/2003
6gemcitabineFDA Link
01/2008 - 02/2003
6Paclitaxel (Taxol)FDA LinkGeneric
01/2007 - 12/2002
6Cisplatin (Platino)FDA LinkGeneric
10/2005 - 10/2003
5titanium silicide (TS-1)IBA
01/2006 - 05/2002
4irinotecan (Camptosar)FDA LinkGeneric
02/2008 - 10/2004
4oxaliplatin (Eloxatin)FDA Link
01/2008 - 08/2005
4hepatoma-derived growth factorIBA
07/2007 - 01/2006
4InterferonsIBA
05/2007 - 11/2002
4TubulinIBA
02/2006 - 09/2002
4Messenger RNA (mRNA)IBA
01/2005 - 01/2002
3Interferon-betaIBA
12/2007 - 12/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2007 - 03/2006
3docetaxel (Taxotere)FDA Link
03/2007 - 08/2003
3XenonIBA
08/2005 - 08/2003
2connexin 26IBA
03/2008 - 02/2008
2doxifluridineIBA
02/2008 - 03/2007
2Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
01/2007 - 08/2006
2TegafurIBA
08/2006 - 01/2006
2UracilIBA
08/2006 - 01/2006
2Cyclin D1IBA
08/2006 - 11/2002
2Angiopoietin-2IBA
05/2006 - 04/2006
2Cadherins (E-Cadherin)IBA
02/2006 - 06/2002
2Proteins (Proteins, Gene)IBA
02/2005 - 11/2002
2Estrogens (Estrogen)FDA Link
11/2004 - 08/2004
2TransferasesIBA
01/2004 - 01/2002
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2002 - 07/2002
2CalciumIBA
09/2002 - 01/2002
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2008
1Dacarbazine (DIC)FDA LinkGeneric
03/2008
1capecitabine (Xeloda)FDA Link
02/2008
1connective tissue-activating peptide (CTAP-III)IBA
01/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2008
1Carbon MonoxideIBA
11/2007
1AngiopoietinsIBA
10/2007
1Proto-Oncogene Protein c-ets-1IBA
10/2007
1Equilibrative Nucleoside Transporter 1IBA
07/2007
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
03/2007
1Hydroxyeicosatetraenoic Acids (HETE)IBA
02/2007
1CholesterolIBA
01/2007
1Matrix Metalloproteinase 16IBA
01/2007
1pullulanIBA
01/2007
1Ethanol (Ethyl Alcohol)IBA
11/2006
1Vitamin K 2 (Vitamin K2)IBA
08/2006
1Angiopoietin-1IBA
03/2006
1Biological Tumor Markers (Tumor Markers)IBA
02/2006
1Leucovorin (Folinic Acid)FDA LinkGeneric
01/2006
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
05/2005
1Thymidine PhosphorylaseIBA
05/2005
1alpha-Fetoproteins (AFP)IBA
01/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2004
1PlatinumIBA
12/2004
1MetallothioneinIBA
12/2004
1alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA
11/2004
1RNA (Ribonucleic Acid)IBA
02/2004
1LigandsIBA
01/2004
1Uridine Diphosphate (UDP)IBA
01/2004
1AcetylglucosamineIBA
01/2004
1GalactosamineIBA
01/2004

Therapy/Procedure

24Drug Therapy (Chemotherapy)
05/2008 - 09/2002
6Combination Drug Therapy (Combination Chemotherapy)
04/2008 - 01/2004
5Hepatectomy
04/2008 - 01/2002
4Lymph Node Excision (Lymph Node Dissection)
01/2007 - 07/2002
3Heterologous Transplantation (Xenotransplantation)
01/2008 - 10/2004
3Liver Transplantation
01/2008 - 01/2006
2Transplants (Transplant)
11/2007 - 11/2007
2Splenectomy
01/2007 - 02/2005
2Gastrectomy
02/2005 - 10/2003
1Stents
01/2008
1Neoadjuvant Therapy
09/2007
1Combined Modality Therapy
09/2004